Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Eggermont; A M M; Suciu; S; Santinami; M; Testori; A; Kruit; W H J; Marsden; J; Punt; C J A; Salès; F; Gore; M; Mackie; R

doi:10.5167/uzh-13909

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Identifier:nobleid.org/w1/20260515/CB0D4DA3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB0D4DA3.svg?ark=w1%2F20260515%2FCB0D4DA3)](https://nobleid.org/work/w1/20260515/CB0D4DA3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Identifier:nobleid.org/w1/20260515/CB0D4DA3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB0D4DA3.svg?ark=w1%2F20260515%2FCB0D4DA3)](https://nobleid.org/work/w1/20260515/CB0D4DA3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work